Abiopharma

🔍 Meister Keith A. (Executive)

Company: GeneDx Holdings Corp. (WGS)

Report Date: 2026-05-07

Detailed Transactions and Holdings:

• Acquired 128,181 shares of Class A Common Stock at $35.46 per share (Direct)
  Date: 2026-05-07 | Code: P | equity_swap_involved: 0 | shares_owned_after: 3,356,331.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 14,786 shares of Class A Common Stock at $36.33 per share (Direct)
  Date: 2026-05-07 | Code: P | equity_swap_involved: 0 | shares_owned_after: 3,371,117.00 | transaction_form_type: 4 | Footnotes: F4, F2
• Acquired 123,393 shares of Class A Common Stock at $37.6 per share (Direct)
  Date: 2026-05-07 | Code: P | equity_swap_involved: 0 | shares_owned_after: 3,494,510.00 | transaction_form_type: 4 | Footnotes: F5, F2
• Acquired 116,412 shares of Class A Common Stock at $38.46 per share (Direct)
  Date: 2026-05-07 | Code: P | equity_swap_involved: 0 | shares_owned_after: 3,610,922.00 | transaction_form_type: 4 | Footnotes: F6, F2
• Acquired 94,356 shares of Class A Common Stock at $39.39 per share (Direct)
  Date: 2026-05-07 | Code: P | equity_swap_involved: 0 | shares_owned_after: 3,705,278.00 | transaction_form_type: 4 | Footnotes: F7, F2
• Acquired 56,630 shares of Class A Common Stock at $40.46 per share (Direct)
  Date: 2026-05-07 | Code: P | equity_swap_involved: 0 | shares_owned_after: 3,761,908.00 | transaction_form_type: 4 | Footnotes: F8, F2
• Acquired 15,745 shares of Class A Common Stock at $38.0 per share (Direct)
  Date: 2026-05-08 | Code: P | equity_swap_involved: 0 | shares_owned_after: 3,777,653.00 | transaction_form_type: 4 | Footnotes: F9, F2
• Acquired 3,396 shares of Class A Common Stock at $38.7 per share (Direct)
  Date: 2026-05-08 | Code: P | equity_swap_involved: 0 | shares_owned_after: 3,781,049.00 | transaction_form_type: 4 | Footnotes: F10, F2
• Acquired 79,144 shares of Class A Common Stock at $40.67 per share (Direct)
  Date: 2026-05-08 | Code: P | equity_swap_involved: 0 | shares_owned_after: 3,860,193.00 | transaction_form_type: 4 | Footnotes: F11, F2
• Acquired 73,104 shares of Class A Common Stock at $41.15 per share (Direct)
  Date: 2026-05-08 | Code: P | equity_swap_involved: 0 | shares_owned_after: 3,933,297.00 | transaction_form_type: 4 | Footnotes: F12, F2
• Acquired 246,734 shares of Class A Common Stock at $38.91 per share (Direct)
  Date: 2026-05-11 | Code: P | equity_swap_involved: 0 | shares_owned_after: 4,180,031.00 | transaction_form_type: 4 | Footnotes: F13, F2
• Acquired 252,734 shares of Class A Common Stock at $39.65 per share (Direct)
  Date: 2026-05-11 | Code: P | equity_swap_involved: 0 | shares_owned_after: 4,432,765.00 | transaction_form_type: 4 | Footnotes: F14, F2
• Acquired 532 shares of Class A Common Stock at $40.35 per share (Direct)
  Date: 2026-05-11 | Code: P | equity_swap_involved: 0 | shares_owned_after: 4,433,297.00 | transaction_form_type: 4 | Footnotes: F15, F2
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-05-07 | Code: H | nature_of_ownership: See footnote | shares_owned_after: 333,144.00 | Footnotes: F16
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-05-07 | Code: H | shares_owned_after: 20,129.00 | Footnotes: F17

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $34.97 to $35.94. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the ranges set forth in footnotes (1), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14) and (15) to this Form 4.
• F2: Investment funds advised by Corvex Management LP ("Corvex") are the direct holders of 4,433,297 shares of the Class A Common Stock, par value $0.0001 per share ("Class A Common Stock") of GeneDX Holdings Corp. (the "Issuer") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex.
• F3: For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.
• F4: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $35.97 to $36.84.
• F5: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $37.05 to $38.04.
• F6: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $38.05 to $39.04.
• F7: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $39.05 to $40.04.
• F8: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $40.05 to $40.66.
• F9: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $37.59 to $38.58.
• F10: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $38.59 to $38.94.
• F11: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $39.95 to $40.94.
• F12: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $40.95 to $41.50.
• F13: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $38.22 to $39.21.
• F14: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $39.22 to $40.21.
• F15: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $40.22 to $40.41.
• F16: CMLS Holdings LLC ("CMLS Holdings") is the record holder of 333,144 shares of the Class A Common Stock reported herein. Mr. Meister is one of two members of the Board of Managers of CMLS Holdings, and Mr. Meister shares voting and investment discretion with respect to the securities held of record by CMLS Holdings reported herein.
• F17: The shares of Class A Common Stock reflected as beneficially owned by Mr. Meister include 20,129 shares of Class A Common Stock that were issued upon the vesting of restricted stock units, that were granted to Mr. Meister in connection with his service on the board of directors of the Issuer.